Together, our findings position endothelial CB1 within the broader landscape of atherosclerosis research and demonstrate that isoflavone phosphates ameliorate disturbed flow-induced endothelial dysfunction in vitro and attenuate atherosclerosis in vivo, indicating their potential translational value. The gene discussed is CNR1; the disease is atherosclerosis.